Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: Poor outcome

Clinical Transplantation

Volumn 20, Issue 4, 2006, Pages 465-470

  Katz, Lior H ^a   Mor, Eitan ^a   Brown, Marius ^a   Bar Nathan, Nathan ^a   Shaharabani, Ezra ^a   Sulkes, Jaqueline ^a   Pappo, Orit ^a,b   Tur Kaspa, Ran ^a   Ben Ari, Ziv ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Biliary complications; Hepatitis C virus; Liver transplantation; Recurrent

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; GLUCOCORTICOID; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PEGINTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; TACROLIMUS;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; BALLOON DILATATION; BILE DUCT DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG TOLERABILITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HEPATITIS C; HUMAN; INCIDENCE; INFECTION COMPLICATION; LEUKOPENIA; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; PRIORITY JOURNAL; RECURRENT INFECTION; REOPERATION; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; STENT; SURVIVAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 33745612713     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2006.00507.x     Document Type: Review

References (21)

1. Gane E, Portmann B, Naoumov N et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996: 334: 815.
2. Prieto M, Berenguer M, Rayon M et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999: 29: 250.
3. Testa G, Crippin JS, Netto GJ et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000: 6: 553.
4. Sanchez-Fueyos A, Resttepo J-C, Quinto I et al. Impact of the recurrence of hepatitis C after liver transplantation on the long term viability of the graft. Transplantation 2002: 73: 56.
5. Berenguer M, Prieto M, Rayon JM et al. Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation. Hepatology 2000: 32: 852.
6. Berenguer M, Ferrell L, Watson J et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000: 32: 673.
7. Everson GT. Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl 2002: 8: s19.
8. Rabkin JM, Orloff SL, Reed MH et al. Biliary tract complications of side-to-side without T tube vs. end-to-end with or without T tube choledochocholedochostomy in liver transplant recipients. Transplantation 1998: 65: 193.
9. Koivusalo A, Isoviemi H, Salmela K et al. Biliary complications in one hundred adult liver transplantations. Scand J Gastroenterol 1996: 31: 506.
10. Jeffrey GP, Brind AM, Ormonde DG et al. Management of biliary tract complications following liver transplantation. Aust N Z J Surg 1999: 69: 717.
11. Portmann BC, Nakanuma Y. Diseases of the bile ducts. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP eds. Pathology of the Liver, 4th edn. London, UK: Churchill Livingstone, 2002: 435.
12. Negi SS, Sakhuja P, Malhotra V, Chaudhary A. Factors predicting advanced hepatic fibrosis in patients with postcholecystectomy bile duct strictures. Arch Surg 2004: 139: 299.
13. Gaglio PJ, Malireddy S, Levitt BS et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors. Liver Transpl 2003: 9: 1028.
14. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997: 349: 825.
15. Fattovitch G, Giustina G, Degos F et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 1997: 112: 463.
16. Hu K-Q, Tong MJ. The long-term outcomes of patients with compensated hepatitis C related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999: 29: 1311.
17. Feray C, Gigou M, Samuel D et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994: 20: 1137.
18. Aronson DC, De Haan J, James J et al. Quantitative aspects of the parenchyma-stroma relationship in experimentally induced cholestasis. Liver 1988: 8: 116.
19. Abdel-Aziz G, Lebeau G, Rescan PY et al. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990: 137: 1333.
20. Weerasooriya VS, White FV, Shepherd RW. Hepatic fibrosis and survival in biliary atresia. J Pediatr 2004: 144: 123.
21. Ramm GA, Nair VG, Bridle KR et al. Contribution of hepatic parenchymal and nonparemchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 1998: 153: 527.